Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

Marco Mina, Renata Boldrini, Arianna Citti, Paolo Romania, Valerio D'Alicandro, Maretta De Ioris, Aurora Castellano, Cesare Furlanello, Franco Locatelli, Doriana Fruci

Research output: Contribution to journalArticlepeer-review

Abstract

Neuroblastoma grows within an intricate network of different cell types including epithelial, stromal and immune cells. The presence of tumor-infiltrating T cells is considered an important prognostic indicator in many cancers, but the role of these cells in neuroblastoma remains to be elucidated. Herein, we examined the relationship between the type, density and organization of infiltrating T cells and clinical outcome within a large collection of neuroblastoma samples by quantitative analysis of immunohistochemical staining. We found that infiltrating T cells have a prognostic value greater than, and independent of, the criteria currently used to stage neuroblastoma. A variable in situ structural organization and different concurrent infiltration of T-cell subsets were detected in tumors with various outcomes. Low-risk neuroblastomas were characterized by a higher number of proliferating T cells and a more structured T-cell organization, which was gradually lost in tumors with poor prognosis. We defined an immunoscore based on the presence of CD3+, CD4+ and CD8+ infiltrating T cells that associates with favorable clinical outcome in MYCN-amplified tumors, improving patient survival when combined with the v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) status. These findings support the hypothesis that infiltrating T cells influence the behavior of neuroblastoma and might be of clinical importance for the treatment of patients.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalOncoImmunology
Volume4
Issue number9
DOIs
Publication statusPublished - Jan 1 2015

Keywords

  • Clinical outcome
  • Correlation network analysis
  • Neuroblastoma
  • Prognostic marker
  • T cells
  • Tumor-infiltrating T lymphocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Fingerprint

Dive into the research topics of 'Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma'. Together they form a unique fingerprint.

Cite this